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T cell.; having DR antigens were shown to be present in high numbers in the thoracic 
duct lymph of patients undergoing long· term drainage. As drainage progresses the pro-
portion of T DR cells in the lymph increases to levels as high as 70% at 6 weeks. These 
cells were demonstrated by showing that T cells isolated by sheep red cell rosetting were 
killed by the action of rabbit anti-B-cell sera and of HLA·DR antisera. The HLA-DR 
specificities found on the T cells corresponded with those on the patients' B lympho-
cytes. 
INTRODUCTION 
Thoracic duct drainage has been used as a method of lymphoid depletion for 
kidney transplantation (1-5). Recently, essentially through the work of Starzl and 
his colleagues (4, 5), it has become apparent that the most effective method of this 
form of immunosuppression is to initiate the drainage well be/ore transplantation. 
We have been testing methods to demonstrate in vitro the optimum time for 
transplantation. 
During this attempt we noted that the characteristics of lymphoid cells in the 
thoracic duct changed markedly after a few weeks of drainage. Others observed 
that the counts dropped dramatically (6, 7) and immature cells appeared (2). As 
reported in our preliminary studies (8), in many patients thoracic duct cells with 
DR markers increased markedly upon drainage. We present here evidence for the 
abundant existence of Tla-positive cells following prolonged drainage. 
MATERIALS AND METHODS 
Thoracic duct lymph was obtained from patients undergoing continuous tho-
racic duct drainage as preparative therapy for kidney or liver transplantation. 
Details of this procedure have been reported previously (4, 5, 9). ~ 
Lymphocytes were prepared from thoracic duct lymph by centrifuge spinning; 
the lymph at 1500g for 10 min. The pelleted cells were suspended in McCoy' s ~ 
media (0.5% fetal calf serum) at a concentration of 10-20 x 106 cells/ml. This i 
suspension was layered over Ficoll and centrifuged for 10 min at 1500g. The j 
interface yielded a homogeneous mononuclear lymphocyte preparation. <4 
B cells were prepared from TD lymphocytes by nylon wool adherence (10). T· 
cells were prepared from nonadherent TD cells using neuraminidase-treated sheep 
erythrocyte rosette formation (11). Rosetted cells were isolated by layering and 
spinning over FicoH and then by lysing with isotonic k~Cl (12). The rosetted 
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were checked for purity by either rerosetting after k~Cf treatment or by 
,_ ......... ,;";"" the percentage of rosetted cells in the Ficoll pellet. Lymphocytes 
had three or more sheep red cells bound to their surface were counted as 
rosettes. 
,'Cytotoxicity was performed by the complement-mediated microcytotoxicity 
(11). Heterologous rabbit anti-DR sera which have been extensively charac-
(13) and recognize common determinants of the alpha and beta polypep-
of DR antigens were used to determine the presence of DR. Alloantisera 
20 - parous women were used to determine the specific HLA-DR groups (DR-
,1,2,3,4,5,7, and MTl). These DR alloantisera have been characterized previously 
-(11, 14). The T-cell antiserum was prepared by intravenous immunization of rab-
o bits with human thymus cells. Data demonstrating the antiserum's specificity has 
been published (15). 
: Surface membrane immunoglobulin was detected (6). Lymphocyte populations 
were incubated with FITC-conjugated rabbit anti-human immunoglobulins (IgG, 
IgM, IgA heavy and light chains), and then washed. Fluorescent cells were 
counted using fluorescence microscopy. 
RESULTS 
o for T cells from thoracic duct lymph produced by rosetting with neuraminidase-
and treated sheep red blood cells did not react, as expected, with the rabbit anti-B-cell 
. this sera. Negative reactions were found with the cells of patients tested during the 
:ion. fIrst and second week of drainage (Fig. 1). As drainage continued, the T cells 
for became more and more susceptible to lysis by the anti-B sera. After more than 6 
weeks, most of the T cells were lysed by anti-B sera, showing that such T cells had 
1 the the DR antigen structures recognized by the antisera. The antisera do not react 
rved against peripheral blood T cells (13), nor did they react against T cells from 
. As patients who had just started on drainage. 
with Further studies were performed to obtain more quantitative information on the 
r the percentage of T cells which may have the DR antigen. The anti-B serum was 
tho-
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FIG. 1. Percentage of la-positive T cells (E rosetting) in thoracic duct following drainage. Each (e) 
represents thoracic duct cells from a different patient. 'Score: ) = 0- [0%; 2 = 11-20%; 4 = 21-40%; 
6_== 41-80%; 8 = 8[-100%. 
34 CICCIARELLI ET AL. 
tested in titrations and, as a control, heterologous anti-T serum (15) was also used· 
(Table 1). To be certain that the isolated T cells were indeed pure T cells, all cells 
were rerosetted to determine the percentage of E cells. The preparations were 
to 97% E-rosetting cells. In the first patient (AC), the anti-T serum killed all cells 
to a dilution of I: 16 whereas the anti-B serum was not cytotoxic. The 10% killing 
was within the background level found in the control negative serum. In all other . 
samples taken from patients after further periods of drainage, the percentage of 
cells reactive with the anti-B serum increased sharply. The anti-T serum con- . 
tinued to kill all preparations. 
In the last patient (CW) in Table 1 as many as 80% of the T cells were killed by 
anti-B serum at a dilution of 1 :64. Since rerosetting has shown 93% to be T cells, . 
we concluded that at least 60% of the T cells were dual marked with DR antigens. 
Since the heterologous antiserum against DR could be suspected to be reacting' 
against other antigens. the T cells from the thoracic duct were tested against 
HLA-DR antisera. Four to six antisera of each of the DR specificities were 
reacted against the T cells. These antisera had been absorbed thoroughly with 
platelets and did not react with peripheral blood T cells. Certain DR antisera were 
cytotoxic to T cells of the thoracic duct (Table 2). Sera which were negative are' 
not shown. All positive reactions were those which were positive on the 
peripheral blood B cells of each individual patient. For example, the first patient 
whose B cells reacted with DR2 and MTl antisera also had T cells which reacted, 
only with those antisera. The HLA-DR antigens which appear on T cells are 
therefore the genetically determined DR of the individual. 
One consistent finding has been that the cytotoxicity produced by the heterolo- . 
go us anti-DR sera is stronger than that produced by the allogeneic antisera. The· 
heterologous sera may be more efficient in producing cytotoxicity or in detecting 
low levels of DR antigens. Alternatively, the "true"' DR is detected by the al-
logeneic antisera and the rabbit sera may contain other impurities. We are not able 
to distinguish between the two possibilities at the present time. 
DISCUSSION 
Dual-marked lymphocytes, that is, T cells with DR antigens have been found 
T cells stimulated by mitogens or allogeneic stimuli (17, 21), on some , .. u,"' .... .., .... 
cells (15, 18, 21), and on erythroid and myeloid precursor cells (18). 
recently they have been found at low levels (about 2% of cells) in the neY'lnnlenl 
blood of healthy persons (18,21,22). The high levels of dual-marked cells 
prolonged thoracic duct drainage reported here have not been encountered 
prior studies. As many as 80% ofT cells produced by sheep red cell rosetting 
lysed by anti-DR sera. The DR sera were from both heterologous and a ... J"' ... ," .. J' ... , 
sources. We reported earlier that the T cells also reacted with zymosan, indie 
that as many as 50% of the T cells had C3 receptors (8). These unprecedented 
levels of dual-marked cells in patients with prolonged drainage may have 
biologic significance. 
We postulate that the unusual state of having mostly TOR-positive cells 
duced in patients on prolonged thoracic duct drainage may be associated with 
ability to induce tolerance in these patients. That is, it is possible that thorac 
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duct drainage removes adult immunocompetent cells and that, upon prolonged 
drainage, only immature cells remain. Thus, a state of immunologic immaturity is 
.. produced: The condition would then be the same as that shown by Medawar and 
his associates in classic immunologic tolerance (23). These immature cells may be 
identifiable by their dual markings. If this is verified, the cell which is susceptible 
to tolerance would be the TOR-positive cell. 
At this point, we can only offer the following as evidence for the hypothesis. 
First, there is a rough correspondence of effectiveness of thoracic duct drainage 
before transplantation (4, 5) and the increase in TOR-positive cells. Whether this 
association indicates a direct relationship, of course, remains to be determined. 
Second, immature cells apparently are often dual marked (15, 18, 21) and with 
maturity, the E+ rosette and DR markers become unique to the T and B cells, 
respectively. Stimulation of T cells may possibly involve a dedifferentiation pro-
cess. 
The current findings also suggest that finding TOR-positive cells in a small 
proportion ofnonnal circulating blood (18,21,22) may not be unusual. Moreover, 
these dual-marked cells may be more common in various immunologic disorders 
in which immature cells spill into the peripheral blood. We have preliminary data 
which show that spleen cells from healthy persons have relatively high levels of 
the TOR-positive cells. Such cells are therefore a normal component of the body's 
cells but apparently do not nonnally occur in high percentages in the blood. 
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